Dongwha Pharm.Co.,Ltd (KRX:000020)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,090.00
+30.00 (0.50%)
At close: Apr 29, 2026
-1.77%
Market Cap 168.80B
Revenue (ttm) 496.39B
Net Income (ttm) 8.69B
Shares Out 27.72M
EPS (ttm) 313.00
PE Ratio 19.46
Forward PE n/a
Dividend 180.00 (2.97%)
Ex-Dividend Date Mar 24, 2026
Volume 91,051
Average Volume 68,660
Open 6,060.00
Previous Close 6,060.00
Day's Range 6,020.00 - 6,120.00
52-Week Range 5,560.00 - 7,140.00
Beta 0.36
RSI 57.86
Earnings Date Mar 30, 2026

About Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health su... [Read more]

Sector Healthcare
Founded 1897
Employees 826
Stock Exchange Korea Stock Exchange
Ticker Symbol 000020
Full Company Profile

Financial Performance

In 2025, Dongwha Pharm.Co.,Ltd's revenue was 496.39 billion, an increase of 6.78% compared to the previous year's 464.87 billion. Earnings were 8.69 billion, an increase of 56.13%.

Financial Statements

News

There is no news available yet.